[go: up one dir, main page]

NO20075727L - Vaksineblanding omfattende B-subenhet av et E.coli varmetoksin og et antigen og en adjuvans - Google Patents

Vaksineblanding omfattende B-subenhet av et E.coli varmetoksin og et antigen og en adjuvans

Info

Publication number
NO20075727L
NO20075727L NO20075727A NO20075727A NO20075727L NO 20075727 L NO20075727 L NO 20075727L NO 20075727 A NO20075727 A NO 20075727A NO 20075727 A NO20075727 A NO 20075727A NO 20075727 L NO20075727 L NO 20075727L
Authority
NO
Norway
Prior art keywords
subunit
adjuvant
antigen
coli heat
heat toxin
Prior art date
Application number
NO20075727A
Other languages
English (en)
Norwegian (no)
Inventor
Marianne Dewerchin
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0510280A external-priority patent/GB0510280D0/en
Priority claimed from GB0524407A external-priority patent/GB0524407D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of NO20075727L publication Critical patent/NO20075727L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20075727A 2005-05-19 2007-11-09 Vaksineblanding omfattende B-subenhet av et E.coli varmetoksin og et antigen og en adjuvans NO20075727L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0510280A GB0510280D0 (en) 2005-05-19 2005-05-19 Vaccines
GB0524407A GB0524407D0 (en) 2005-11-30 2005-11-30 Vaccines
PCT/GB2006/001832 WO2006123155A2 (en) 2005-05-19 2006-05-18 Vaccine composition comprising b-subunit of e. coli heat toxin and an atigen and an adjuvant

Publications (1)

Publication Number Publication Date
NO20075727L true NO20075727L (no) 2008-02-15

Family

ID=37431620

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075727A NO20075727L (no) 2005-05-19 2007-11-09 Vaksineblanding omfattende B-subenhet av et E.coli varmetoksin og et antigen og en adjuvans

Country Status (13)

Country Link
US (1) US20090035330A1 (ru)
EP (1) EP1881844A2 (ru)
JP (1) JP2008540625A (ru)
KR (1) KR20080018201A (ru)
AU (1) AU2006248725A1 (ru)
BR (1) BRPI0610061A2 (ru)
CA (1) CA2608979A1 (ru)
EA (1) EA200702254A1 (ru)
IL (1) IL187008A0 (ru)
MA (1) MA29459B1 (ru)
MX (1) MX2007014390A (ru)
NO (1) NO20075727L (ru)
WO (1) WO2006123155A2 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229045A1 (en) * 2001-02-01 2002-08-07 Institut Curie Universal carrier for targeting molecules to Gb3 receptor expressing cells
TWI457133B (zh) * 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
JP2010505433A (ja) 2006-10-12 2010-02-25 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー テロメラーゼ逆転写酵素融合タンパク質、これをコードするヌクレオチドおよびこれの用途
EP2034022A1 (en) 2007-09-10 2009-03-11 Universite Libre De Bruxelles Leukotriene B4 binding soluble lipocalin receptor from ixodes ricinus
EP2045263A1 (en) 2007-10-02 2009-04-08 Universite Libre De Bruxelles Identification and molecular characterisation of salivary metalloproteases expressed in the tick salivary glands
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
MX2011013566A (es) * 2009-06-19 2012-06-28 Eyegene Inc Vacunas para cancer cervical.
AR077636A1 (es) 2009-07-08 2011-09-14 Abbott Biologicals Bv Vacuna viral y uso de la misma
CN106170551B (zh) 2013-12-16 2020-01-07 财团法人农业科技研究院 生产不耐热肠毒素b亚单位的质粒、方法及其套组
CA2957513A1 (en) * 2014-08-08 2016-02-11 Idemitsu Kosan Co., Ltd. Agent for controlling porcine reproductive and respiratory syndrome
AU2015329070B2 (en) 2014-10-07 2018-11-22 Nec Corporation Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
TW202115102A (zh) 2015-03-09 2021-04-16 日商賽多利克公司 來自gpc3之胜肽、使用此胜肽之用於治療或預防癌症之醫藥組成物、免疫誘導劑、及抗原呈現細胞之製造方法
TWI738646B (zh) * 2015-04-07 2021-09-11 日商賽多利克公司 醫藥組成物
BR112019006075A2 (pt) 2016-10-11 2019-06-18 Cytlimic Inc medicamento
CN111333734B (zh) * 2020-03-31 2022-05-03 中国人民解放军军事科学院军事医学研究院 一种百日咳丝状血凝素融合蛋白及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278302A (en) * 1988-05-26 1994-01-11 University Patents, Inc. Polynucleotide phosphorodithioates
US5843464A (en) * 1995-06-02 1998-12-01 The Ohio State University Synthetic chimeric fimbrin peptides
US5666153A (en) * 1995-10-03 1997-09-09 Virtual Shopping, Inc. Retractable teleconferencing apparatus
US6303347B1 (en) * 1997-05-08 2001-10-16 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6764840B2 (en) * 1997-05-08 2004-07-20 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6558670B1 (en) * 1999-04-19 2003-05-06 Smithkline Beechman Biologicals S.A. Vaccine adjuvants
IL145982A0 (en) * 1999-04-19 2002-07-25 Smithkline Beecham Biolog Vaccines
GB0411411D0 (en) * 2004-05-21 2004-06-23 Glaxosmithkline Biolog Sa Vaccines

Also Published As

Publication number Publication date
WO2006123155A2 (en) 2006-11-23
EP1881844A2 (en) 2008-01-30
US20090035330A1 (en) 2009-02-05
MA29459B1 (fr) 2008-05-02
IL187008A0 (en) 2008-02-09
CA2608979A1 (en) 2006-11-23
MX2007014390A (es) 2008-02-12
AU2006248725A1 (en) 2006-11-23
KR20080018201A (ko) 2008-02-27
BRPI0610061A2 (pt) 2016-11-29
WO2006123155A3 (en) 2007-07-19
JP2008540625A (ja) 2008-11-20
EA200702254A1 (ru) 2008-06-30

Similar Documents

Publication Publication Date Title
NO20075727L (no) Vaksineblanding omfattende B-subenhet av et E.coli varmetoksin og et antigen og en adjuvans
ATE426412T1 (de) Adjuvante influenza-vakzine
WO2005112991A3 (en) Vaccines
IS7593A (is) Bólusetningasamsetning sem samanstendur af transferrín bindi prótíni og HSF úr gram-neikvæðum bakteríum
ATE491471T1 (de) Adjuvantien für dns impstoffe basierend auf imidazochinoline
NO20063254L (no) Immunstimulerende sammensetning omfattende minst en toll-lignende reseptor 7 eller toll-lignende reseptor 8 agonist og en toll-lignende reseptor 4 agonist
DK1187629T3 (da) Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
DK1185691T3 (da) Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf
DK1459766T3 (da) Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner
BR0310042A (pt) Vacinas de combinação mucosal para meningite bacteriana
ATE539767T1 (de) Adjuvans auf basis von polyinosinsäure/polycytidylsäure
DE60011560D1 (de) Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert
ATE392216T1 (de) Mycobakterieller impfstoff
DE60207277D1 (de) Bakterieller impfstoff
WO2006113907A3 (en) Escherichia coli o157:h7 proteins and uses thereof
ITTN20020016A1 (it) Ventilconvettore ad effetto convettivo e radiante.
MX2012004622A (es) Adyuvante para vacunas, vacunas que lo comprenden y usos.
ATE518012T1 (de) Isolate des das reproduktions- und atemwegssyndrom verursachenden schweinevirus und ihre verwendung
ATE355853T1 (de) Heterologer schutz, induziert durch immunisierung mit der invaplex-vakzine
ATE538349T1 (de) Raumbeheizungseinrichtung
WO2007062832A3 (en) Vaccines containing non-live antigenic vectors
ATE450270T1 (de) Impstoff gegen mikrobielle pathogenen
BRPI0604365A (pt) polipeptìdeo isolado, composição de vacina anti-carrapato de múltiplas espécies, e, uso dos mesmos
DE60126490D1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application